SLC26A9 and cystic fibrosis: TMEM16A and SLC26A9 attenuate airway inflammation in cystic fibrosis (CF)7, prevent mucus obstruction during airway inflammation and attenuate the intestinal obstructive phenotype in CF mice6,8.